|
Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
| 1.806,50 GBX | +0,11% |
|
-0,44% | -0,88% |
| 11:12 | GSK-medicijn goedgekeurd in China voor behandeling van ongecontroleerd astma | AN |
| 08:11 | GSK meldt goedkeuring van Trelegy Ellipta in China voor volwassenen | RE |
Belangrijkste concurrenten
Toevoegen aan een lijst 0 geselecteerde | k/w-verhouding (Y) | Koers-boekwaarde (Y) | PEG (Y) | EV/omzet (Y) | Beurskap. / EBITDA (Y) | Beurskap. / EBIT (Y) | Dividendrendement (Y) | Kap.($) | |
|---|---|---|---|---|---|---|---|---|---|
 | 13.34x | 5.03x | 0.12x | 2.66x | 7.69x | 9x | 3,59% | 97,69 mld. | |
| 47.41x | 36.37x | 0.49x | 15.69x | 34.96x | 37.84x | 0,54% | 974 mld. | |
| 21.13x | 6.72x | 0.27x | 5.88x | 16.33x | 17.92x | 2,36% | 526 mld. | |
| 63.2x | 911.91x | 1.42x | 7.25x | 17.38x | 18.01x | 3% | 385 mld. | |
| 20.86x | 7.11x | 0.34x | 5.07x | 12.57x | 14.2x | 2,85% | 376 mld. | |
| 28.05x | 6.32x | 0.62x | 5.22x | 15.48x | 16.3x | 1,77% | 284 mld. | |
| 20.34x | 6.51x | 0.97x | 5.38x | 12.66x | 13.72x | 2,82% | 279 mld. | |
| 17.17x | 9.32x | 8.22x | 6.07x | 12.54x | 14.52x | 2,93% | 277 mld. | |
| 13.98x | 5.03x | 0.88x | 4.56x | 9.84x | 11.06x | 2,96% | 271 mld. | |
| 27.12x | 20.66x | 0.39x | 6.37x | 10.91x | 14.62x | 2,76% | 187 mld. | |
| 19.57x | 7.22x | 0.01x | 6.01x | 10.99x | 13.23x | 2,53% | 163 mld. | |
| 13.01x | 1.64x | 0.31x | 3.1x | 7.77x | 9.05x | 6,55% | 148 mld. | |
| 30.12x | 6.25x | -0.04x | 9.08x | 19.64x | 20.39x | -.--% | 119 mld. | |
| 11.89x | 1.24x | 0.26x | 2.5x | 8.15x | 8.99x | 5,16% | 113 mld. | |
| 14.08x | 5.58x | -0.07x | 3.04x | 9.08x | 9.61x | 4,48% | 112 mld. | |
| 32.26x | 7x | 3.03x | 10.38x | 20.38x | 21.77x | 3,02% | 87,31 mld. | |
| 44.54x | 6.49x | 1.33x | 10.76x | 35.45x | 37.09x | 0,47% | 56,71 mld. | |
| 188.14x | 1.32x | -1.73x | 1.64x | 7.87x | 14.04x | 0,25% | 50,98 mld. | |
| 42.05x | 1.16x | 0.56x | 2.62x | 9.79x | 27.7x | 3,98% | 50,15 mld. | |
| Gemiddelde | 35,17x | 55,42x | 0,92x | 5,96x | 14,71x | 17,32x | 2,74% | 239,86 mld. | |
| Gewogen gemiddelde per kap. | 32,19x | 89,77x | 1,03x | 7,74x | 18,17x | 20,14x | 2,36% |
- Beurs
- Aandelen
- Koers GSK
- Sector GSK plc
- Sectorale waarderingen
Kies jouw editie
Alle financiële informatie op nationaal niveau
